Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Elental is a good long-term treatment for Crohn's disease, similar to 6-mercaptopurine but with fewer side effects.

The new cream is safe and effective for mild to moderate atopic dermatitis.

Bullous pemphigoid can look like erythema multiforme, so awareness is needed for proper treatment.

The data suggests that dosing differences can help manage spasticity in patients with upper motor neuron dysfunction.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Four antibodies were developed to help study hair follicle cell differentiation.

Ocrelizumab helped control lupus in a pregnant patient, leading to the birth of a healthy baby.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

Dupilumab may help regrow hair in people with atopic dermatitis.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

ABCD1 gene mutations cause adrenomyeloneuropathy, leading to symptoms like limb weakness and spasticity, with management focusing on rehabilitation and spasticity treatment.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Etretinate has only moderate effects on localized scleroderma and lichen sclerosus.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

Afatinib often causes skin problems that need proactive management.

The hydrogel promotes better wound healing by creating a fetal-like environment.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

RXRa is crucial for Th2 immune cell development and may link nutrition to immune health.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

Belimumab may cause hair loss in lupus patients.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.